Spect

Closed

Value-based retinal screening in primary care to prevent blindness.

Palo Alto, United States · Founded 2017

Employees
1–10
Founded
2017
Last Round
SeedNov 2021
Rounds
2

About

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

Summary

Spect is an Artificial Intelligence company based in Palo Alto, United States, founded in 2017. Its most recent funding was a Seed round in Nov 2021. Investors include Morado Ventures, AME Cloud Ventures and XTX Ventures.

Tech & App Stack

4 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies